Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Second quarter net product sales were $73.3 million, a 46% increase over 2016.Strong acceleration in Trokendi XR prescription growth following April launch in migraine prophylaxis in adults and...
-
ROCKVILLE, Md., July 19, 2017 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the...
-
ROCKVILLE, Md., June 21, 2017 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the...
-
ROCKVILLE, Md., June 01, 2017 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the...
-
Net product sales were $56.4 million, a 31% increase over 2016.Operating income was $16.8 million, a 161% increase over 2016.Diluted earnings per share were $0.19, increasing by 138% over 2016.Early...
-
ROCKVILLE, Md., April 26, 2017 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the...
-
ROCKVILLE, Md., April 05, 2017 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the...
-
ROCKVILLE, Md., March 07, 2017 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the...
-
ROCKVILLE, Md., March 06, 2017 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the...
-
Fourth quarter 2016 net product sales were $61.1 million, a 43% increase over 2015.Fourth quarter operating income was $16.3 million, a 107% increase over 2015.Fourth quarter diluted earnings per...